Ratings
3 / 5
Dividend
1 / 5
Investing
2 / 5
ESG
Roche is a Swiss biopharmaceutical and diagnostic company. The firm’s best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Overview
- Company Name: Roche Holding AG
- Country/Region: Switzerland
- ISIN: CH0012032113
- Listing Date:
- Industry: Health Care / Pharmaceuticals